Sharda Cropchem Ltd
Sharda Cropchem Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #9 of 23 in Fertilizers & Agrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Revenue growth guidance for FY27 is expected to be 10% to 15%, with potential to go higher or lower based on various factors (Page 12, 13). Revenue growth guidance for FY27 is expected between 10% to 15%, with potential to go higher or lower based on external factors.
From Sharda Cropchem Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Revenue growth guidance for FY27 is expected to be 10% to 15%, with potential to go higher or lower based on various factors (Page 12, 13).
- Volume growth projection for FY27 is around 15% (Page 13).
- Growth is driven by both existing product portfolio and new registrations, though registration timelines are uncertain and approvals have slowed down (Page 11, 17-18).
- Limited competition due to extended registration approval timelines may help in maintaining/improving realizations (Page 18).
- Company has a global market share of about 5%, implying significant scope for market share expansion which can lead to business growth (Page 18).
- Non-agro segment expected to grow 5%-10% with improving margins (Page 14).
2 more points from Sharda Cropchem Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Sharda Cropchem Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- For FY26, Sharda Cropchem's capital expenditure (CAPEX) stood at INR 505 crores.
- The company focuses on product registrations and expanding its market share globally, which may imply investment in registrations and marketing.
- The business model emphasizes marketing and registrations rather than trading or manufacturing expansions.
- Growth is expected from increasing registrations, market share, and leveraging an IP-led model, rather than large-scale CAPEX.
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sharda Cropchem Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Sharda Cropchem Ltd said on order book & pipeline — free account, 30 seconds.
Sharda Cropchem Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹1.1K Cr, net profit ₹88 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Sharda Cropchem Ltd's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- Rama Phosphates Ltd (Q4 FY26)
Revenue grew by 20% year-on-year (Page 8). Key investor presentation takeaways from Rama Phosphates's Q4 FY26 investor presentation — and how it ranks against s
- Khaitan Chemicals & Fertilizers Ltd (Q4 FY26)
Q4-FY26 Operational Revenue: INR 1,930 million, up 20.1% YoY (from INR 1,607 million in Q4-FY25). Key investor presentation takeaways from Khaitan Chemical's Q4
- Dhansa Labs Ltd (Q4 FY26)
120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…
- Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Dharmaj CropGood growth2
- Anya Polytech &Good growth1
- M B Agro Prod.Good growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Sharda Cropchem Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Sharda Cropchem Ltd Q4 FY26 results?
Revenue growth guidance for FY27 is expected to be 10% to 15%, with potential to go higher or lower based on various factors (Page 12, 13). Revenue growth guidance for FY27 is expected between 10% to 15%, with potential to go higher or lower based on external factors.
What is Sharda Cropchem Ltd share price analysis?
Sharda Cropchem Ltd currently shows a neutral. The stock trades at a P/E of 11.3 with a market cap of ₹7,095 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sharda Cropchem Ltd planning capital expenditure?
For FY26, Sharda Cropchem's capital expenditure (CAPEX) stood at INR 505 crores.
Keep Sharda Cropchem Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.